Review of backscatter measurement in kilovoltage radiotherapy using novel detectors and reduction: From lack of underlying scattering material

Journal of Applied Clinical Medical Physics

Volumn 14, Issue 6, 2013, Pages 5-17

  Eaton, David J ^a   Doolan, Paul J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Backscatter factor; GAFCHROMIC film; Kilovoltage; Lead shielding; Radiotherapy

Indexed keywords

EID: 84888413144     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v14i6.4358     Document Type: Review

References (27)

1. Ma C-M, Coffey CW, DeWerd LA, et al. AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology. Med Phys. 2001;28(6):868-93.
2. Klevenhagen SC, Aukett RJ, Harrison RM, Moretti C, Nahum AE, Rosser KE. The IPEMB code of practice for the determination of absorbed dose for X-rays below 300 kV generating potential (0.035 mm Al-4 mm Cu HVL; 10-300 kV generating potential). Phys Med Biol. 1996;41(12):2605-25.
3. Butson MJ, Cheung T, Yu PKN. Radiochromic film for verification of superficial x-ray backscatter factors. Australas Phys Eng Sci Med. 2007;30(4):269-73.
4. Kim J, Hill R, Claridge Mackonis E, Kuncic Z. An investigation of backscatter factors for kilovoltage x-rays: a comparison between Monte Carlo simulations and Gafchromic EBT film measurements. Phys Med Biol. 2010;55(3):783-97.
5. Smith L, Hill R, Nakano M, Kim J, Kuncic Z. The measurement of backscatter actors of kilovoltage X-ray beams using Gafchromic™ EBT2 film. Australas Phys Eng Sci Med. 2011;34(2):261-66.
6. Mart CJ, Elson HR, Lamba MAS. Measurement of low-energy backscatter factors using GAFCHROMIC film and OSLDs. J Appl Clin Med Phys. 2012;13(6):126-33.
7. Eaton DJ, Barber E, Ferguson L, Simpson GM, Collis CH. Radiotherapy treatment of keloid scars with a kilovoltage X-ray parallel pair. Radiother Oncol. 2012;102(3):421-23.
8. Klevenhagen SC. The build-up of backscatter in the energy range 1 mm Al to 8 mm Al HVT (radiotherapy beams). Phys Med Biol. 1982;27(8):1035-43.
9. Huq MS, Venkataramanan N, Meli JA. The effect on dose of kilovoltage x-rays backscattered from lead. Int J Radiat Oncol Biol Phys. 1992;24(1):171-75.
10. Lanzon PJ, Sorell GC. The effect of lead underlying water on the backscatter of X-rays of beam qualities 0.5 to 8 mm Al HVT. Phys Med Biol. 1993;38(8):1137-44.
11. Das IJ and Chopra KL. Backscatter dose perturbation in kilovoltage photon beams at high atomic number interfaces. Med Phys. 1995;22(6):767-73.
12. Healy BJ, Sylvander S, Nitschke KN. Dose reduction from loss of backscatter in superficial x-ray radiation therapy with the Pantak SXT 150 unit. Australas Phys Eng Sci Med. 2008;31(1):49-55.
13. Hill R, Healy B, Holloway L, Baldock C. An investigation of dose changes for therapeutic kilovoltage X-ray beams with underlying lead shielding. Med Phys. 2007;34(7):3045-53.
14. Butson MJ, Cheung T, Yu PKN. Measurement of dose reductions for superficial x-rays backscattered from bone interfaces. Phys Med Biol. 2008;53(17):N329-N336.
15. Chow JC and Owrangi AM. Surface dose reduction from bone interface in kilovoltage X-ray radiation therapy: a Monte Carlo study of photon spectra. J Appl Clin Med Phys. 2012;13(5):215-22.
16. Aukett RJ, Burns JE, Greener AG, et al. Addendum to the IPEMB code of practice for the determination of absorbed dose for x-rays below 300 kV generating potential (0.035 mm Al-4 mm Cu HVL). Phys Med Biol. 2005;50(12):2739-48.
17. Nelson VK, Hill RF. Backscatter factor measurements for kilovoltage X-ray beams using thermoluminescent dosimeters (TLDs). Radiat Meas. 2011;46(12):2097-99.
18. Munckaf Rosenschöld P, Nilsson P, Knöös T. Kilovoltage x-ray dosimetry - an experimental comparison between different dosimetry protocols. Phys Med Biol. 2008;53(16):4431-42.
19. Chica U, Anguiano M, Lallena AM. Study of the formalism used to determine the absorbed dose for low-energy x-ray beams. Phys Med Biol. 2008;53(23):6963-77.
20. Chica U, Flórez G, Anguiano M, Lallena AM. A simple analytical expression to calculate the backscatter factor for low energy X-ray beams. Phys Med. 2011;27(2):75-80.
21. Kairn T, Aland T, Kenny J. Local heterogeneities on early batches of EBT2 film: a suggested solution. Phys Med Biol. 2010; 55(15):L37-L42.
22. Richley L, John AC, Coomber H, Fletcher S. Evaluation and optimization of the new EBT2 radiochromic film dosimetry system for patient dose verification in radiotherapy. Phys Med Biol. 2010; 55(9):2601-17.
23. Aland T, Kairn T, Kenny J. Evaluation of a Gafchromic EBT2 film dosimetry system for radiotherapy quality assurance. Australas Phys Eng Sci Med. 2011;34(2):251-60.
24. Lewis D, Micke A, Yu X, Chan MF. An efficient protocol for radiochromic film dosimetry combining calibration and measurement in a single scan. Med Phys. 2012;39(10):6339-50.
25. Benmakhlouf H, Fransson A, Andreo P. Influence of phantom thickness and material on backscatter factors for diagnostic x-ray beam dosimetry. Phys Med Biol. 2013;58(2):247-60.
26. Yu PKN, Butson MJ. Measurement of effects of nasal and facial shields on delivered radiation dose for superficial x-ray treatments. Phys Med Biol. 2013;58(5):N95-N102.
27. Mayles P, Nahum A, Rosenwald JC, editors. Handbook of radiotherapy physics: theory and practice. Boca Raton (FL): Taylor and Francis Group; 2007.